Hopace 10 Tablet contains Ramipril 10 mg, an angiotensin-converting enzyme (ACE) inhibitor primarily indicated for the management of hypertension and congestive heart failure. By inhibiting the ACE enzyme, Ramipril reduces the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation, decreasing peripheral vascular resistance, and lowering blood pressure. This mechanism also reduces the workload on the heart, making Hopace 10 effective in improving cardiac function in patients with heart failure. Additionally, Ramipril has been shown to provide renal protection in patients with diabetic nephropathy and to reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in high-risk patients. The recommended dosage should be individualized based on patient response and clinical condition, with careful monitoring of blood pressure, renal function, and serum electrolytes during therapy. Common side effects include cough, dizziness, hypotension, and hyperkalemia, while rare but serious adverse effects may involve angioedema and renal impairment. Hopace 10 should be used cautiously in patients with renal artery stenosis, pregnancy, or a history of hypersensitivity to ACE inhibitors. It is essential to consult a healthcare professional before initiating treatment with Hopace 10 Tablet.